Corindus Vascular Robotics’ CorPath GRX system—the world’s only FDA-approved and CE-marked robotic platform for percutaneous coronary intervention (PCI) and peripheral vascular intervention—was used to successfully perform a remote PCI from more than 350 miles away during this year’s EuroPCR congress.
Three-year results of the BIO-RESORT study, presented at EuroPCR this week in Paris, put Biotronik’s ultrathin Orsiro stent ahead of two other competitors in terms of target lesion failure and revascularization.
Atrial fibrillation patients with coronary artery disease pose a delicate balancing act for physicians. A growing awareness of bleeding vs. ischemic risks could soon lead to a steadier therapeutic response.
Coronary artery bypass grafting (CABG) surgery beat out stent placement with percutaneous coronary intervention (PCI) in a recent study of patients with multivessel coronary artery disease. Patients saw lower risks of death, hospital readmission and revascularization with the former procedure.
Around a quarter of heart patients who undergo percutaneous coronary intervention (PCI) are readmitted to the hospital for unplanned reasons within six months of their procedure, researchers report in JACC: Cardiovascular Interventions.
Percutaneous coronary intervention is being offered to a greater proportion of older adults with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock over the past two decades—a trend that’s been paralleled by declining mortality rates, according to a study in the Journal of the American College of Cardiology.
More than 80% of stable patients with ST-segment elevation myocardial infarction (STEMI) are treated in the intensive care unit despite only 16% of them experiencing complications that require an ICU stay, according to a U.S. registry analysis published in JACC: Cardiovascular Interventions.
Domestic responsibilities put a damper on career satisfaction for proceduralist mothers more than for physician mothers in nonprocedural specialties, suggests a study published April 10 in JAMA Surgery.
A new pilot study out of Germany suggests a comic-style graphic supplement can improve the informed consent process before coronary angiography by putting patients at ease and helping them understand the procedure.
Once the artery has been opened with PCI, the treatment involves mixing a patient’s own blood with oxygenated saline and then infusing that superoxygenated mixture to the targeted ischemic area for 60 minutes.